Date: August 1, 2026
Board Meeting Outcomes
- The Nomination and Remuneration Committee approved allotment of 20,01,336 Equity Shares of ₹2 each
- Approval was granted via resolution passed by circulation on July 31, 2026
- Shares were allotted to eligible optionees under SeQuent ESOP 2020
- Exercise price was ₹86 per equity share
- The new shares will rank pari passu with existing equity shares
Financial Impact
- Issued and paid-up equity share capital increases from ₹87,37,50,954 (43,68,75,477 shares) to ₹87,77,53,626 (43,88,76,813 shares)
- Increase represents approximately 0.46% dilution in equity share capital
Other Operational / Legal / Strategic Disclosures
- Disclosure was made promptly after receiving committee approval late on July 31, 2026
- The company formally notified BSE Limited and National Stock Exchange of India Limited